welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

83% Informative

Janux Therapeutics Inc. (NASDAQ:JANX) is a clinical-stage biopharmaceutical company that develops immunotherapies for cancer.

The company is concentrating its efforts on its TRACTr therapy, specifically JANX007, which targets prostate-specific membrane antigen antigen PSMA.

Janux Therapeutics Inc. (NASDAQ:JANX) has not yet met all the benchmarks necessary to establish a competitive advantage and attract a pharmaceutical acquisition.

Overall, JANX ranks 1st on our list of the best up and coming stocks to buy according to Wall Street Analysts.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.